Evidence map›Paper›PMID 28179274›Full record

ReviewBlood2017

Mouse models of MLL leukemia: recapitulating the human disease.

Thomas A Milne

Open access · bronzeAbstract readReview
In one paragraph

Review in Blood, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 99 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Thomas A MilneWeatherall Institute of Molecular Medicine, Medical Research Council Molecular Haematology Unit, University of Oxford, Oxford, United Kingdom.ORCID 0000-0002-0413-4271
University of Oxford · GB

Funding

Medical Research Council MC_UU_00016/6Medical Research Council MC_UU_12009/6
6 · The paper itself

Abstract

Chromosome translocations involving the mixed lineage leukemia (

Indexed as

Disease Models, AnimalOncogene Proteins, FusionAnimalsAntineoplastic AgentsCarcinogenesisDNA-Binding ProteinsGene ExpressionHistone-Lysine N-MethyltransferaseHumansLeukemia, Myeloid, AcuteMiceMice, TransgenicMyeloid-Lymphoid Leukemia ProteinPrecursor Cell Lymphoblastic Leukemia-LymphomaSpecies SpecificityTranscriptional Elongation FactorsAFF1 protein, humanAntineoplastic AgentsDNA-Binding ProteinsELL protein, humanHistone-Lysine N-MethyltransferaseKMT2A protein, humanKmt2a protein, mouseMyeloid-Lymphoid Leukemia ProteinOncogene Proteins, FusionTranscriptional Elongation Factors

Identifiers

PMID28179274
PMCPMC5399479
OpenAlexW2586890927

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.